MedPath

Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI

Phase 4
Completed
Conditions
Pregnancy
Interventions
Registration Number
NCT02638285
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

To compare pregnancy rate by Human Chorionic Gonadotropin (HCG) administration and urinary Luteinizing Hormone (LH) surge method for insemination in patients undergoing Intrauterine Insemination (IUI) at Montaserieh infertility center.

The present study comprised 309 infertile women candidate for IUI, randomly divided into LH surge and HCG groups (assign the number for each patient, odds number for LH and even number for HCG group). All patients were subjected to baseline ultrasound and received clomiphene citrate before undergoing serial transvaginal sonography. LH was measured using LH kit when 2-5 follicles (18-20 mm) appeared in LH surge group, and if positive, IUI was performed after 24 hours. In HCG group, the patients received HCG 1000 units and underwent IUI after 36 hours. The pregnancy rate was then compared in LH and HCG groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
86
Inclusion Criteria
  • infertile women candidate for IUI
Exclusion Criteria
  • women with negative urinary LH surge which required HCG administration,
  • those with more than 5 follicles who had to use LH kit and not receive HCG to avoid ovarian hyperstimulation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
clomiphene citrateLHclomiphene citrate
LH groupClomipheneLH group
HCG groupClomipheneHCG group
HCG groupHCGHCG group
clomiphene citrateHCGclomiphene citrate
LH groupLHLH group
Primary Outcome Measures
NameTimeMethod
pregnancy rateTwo weeks after IUI
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Health Policy Research Center

🇮🇷

Shiraz, Fars, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath